Pfizer (United States)
New York, USA · 13 authors
Pfizer (United States) (New York, USA): 13 authors and 7 papers in the de novo peptide sequencing catalog.
Papers (7)
- Benchmarking deep learning models and classical de novo sequencing tools for immunopeptidomics (2023, Proceedings of the 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics)
- Constrained De Novo Sequencing of Conotoxins (2012, Journal of Proteome Research)
- Primary sequence determination of a monoclonal antibody against α-synuclein using a novel mass spectrometry-based approach (2012, International Journal of Mass Spectrometry)
- Constrained De Novo Sequencing of Peptides with Application to Conotoxins (2011, Lecture Notes in Computer Science)
- A Hybrid Method for Peptide Identification Using Integer Linear Optimization, Local Database Search, and Quadrupole Time-of-Flight or OrbiTrap Tandem Mass Spectrometry (2008, Journal of Proteome Research)
- Algorithms for de novo peptide sequencing using tandem mass spectrometry (2004, Drug Discovery Today: BIOSILICO)
- A Suboptimal Algorithm for De Novo Peptide Sequencing via Tandem Mass Spectrometry (2003, Journal of Computational Biology)